Countervail wins business plan competition at 8th annual Five Ventures conference. Out of 130 competing companies, Countervail wins the Biotechnology – Pharmaceutical division for best business plan presentation. April 30, 2009 • admin • General News, Uncategorized Read More »
Countervail’s principal investigator presents at 2009 NINDS CounterACT meeting in Washington, DC. Dr. Edson Albuquerque presents additional data on galantamine’s effectiveness in preserving survival and prevention of neural cell damage from nerve agent exposure. April 14, 2009 • admin • General News Read More »